Top

Published in:

01-04-2009 | 2008 ssat quickshot presentation

Leukocyte Depletion in Allogeneic Blood Transfusion Does Not Change the Negative Influence on Survival Following Transthoracic Resection for Esophageal Cancer

Authors: Frederike C. Ling, Arnulf H. Hoelscher, Daniel Vallböhmer, Daniel Schmidt, Susanne Picker, Birgit S. Gathof, Elfriede Bollschweiler, Paul M. Schneider

Published in: Journal of Gastrointestinal Surgery | Issue 4/2009

Abstract

Background

Perioperative transfusion of allogeneic blood has been hypothesized to have an immunomodulatory effect and influence survival in several cancer types. This study evaluates the association between receipt of leucocyte-depleted and non-depleted allogeneic blood and survival following esophagectomy for cancer.

Methods

A retrospective analysis was performed including 291 patients with esophageal cancers who underwent transthoracic en bloc esophagectomy and extended mediastinal lymphadenectomy. Neoadjuvant chemoradiation was administered in 152 (52.2%) patients. Perioperative blood transfusions were quantified and the potential prognostic cutoff for transfused units was calculated according to LeBlanc.

Results

The median number of perioperative blood transfusions was 2 (0–24), and 106 patients (36.4%) received no transfusions. Patients with one or less blood transfusion showed a significantly improved survival compared to patients receiving more than one unit (p < 0.009). In multivariate analysis, blood transfusion categories showed significance (p < 0.015) next to pT, pN, pM category, and residual tumor categories (R-categories). Separate analysis of 183 patients treated after the mandatory introduction of leukocyte-depleted blood transfusions detected a strong tendency, but no significant difference in survival for patients getting one or less or more than one transfusion (p = 0.056). Receipt of leukocyte-depleted versus non-depleted units, however, had no influence on survival (p = 0.766).

Conclusions

The need for perioperative allogeneic blood transfusions is significantly associated with poorer survival following resection for esophageal cancer by univariate and multivariate analysis. Our data suggest that the reduction of leukocytes in allogeneic transfusions is not sufficient to overcome the negative influence on survival.

Fields RC, Meyers BF. The effects of perioperative blood transfusion on morbidity and mortality after esophagectomy. Thorac Surg Clin 2006;16:75–86. doi:10.1016/j.thorsurg.2006.01.005.PubMedCrossRef

Swisher SG, Holmes EC, Hunt KK, Gornbein JA, Zinner MJ, McFadden DW. Perioperative blood transfusions and decreased long-term survival in esophageal cancer. J Thorac Cardiovasc Surg 1996;112:341–348. doi:10.1016/S0022-5223(96)70260-X.PubMedCrossRef

Nozoe T, Miyazaki M, Saeki H, Ohga T, Sugimachi K. Significance of allogenic blood transfusion on decreased survival in patients with esophageal carcinoma. Cancer 2001;92:1913–1918. doi:10.1002/1097-0142(20011001)92:7<1913::AID-CNCR1709>3.0.CO;2-8.PubMedCrossRef

Langley SM, Alexiou C, Bailey DH, Weeden DF. The influence of perioperative blood transfusion on survival after esophageal resection for carcinoma. Ann Thorac Surg 2002;73:1704–1709. doi:10.1016/S0003-4975(02)03508-7.PubMedCrossRef

Tachibana M, Tabara H, Kotoh T, Kinugasa S, Dhar DK, Hishikawa Y, Masunaga R, Kubota H, Nagasue N. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer. AJG 1999;94:759–765.

Dresner SM, Lamb PJ, Shenfine J, Hayes N, Griffin SM. Prognostic significance of perioperative blood transfusion following radical resection for oesophageal carcinoma. Eur J Surg Oncol 2000;26:492–497. doi:10.1053/ejso.1999.0929.PubMedCrossRef

Francis DM, Clunie GJ. Influence of the timing of blood transfusion on experimental tumor growth. J Surg Res 1993;54:237–241. doi:10.1006/jsre.1993.1037.PubMedCrossRef

Bordin JO, Bardossy L, Blajchman MA. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: The importance of the timing of the leukodepletion. Blood 1994;84:344–348.PubMed

Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP. Allogeneic blood transfusion-induced enhancement of tumor growth: Two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 1993;81:1880–1882.PubMed

10.

Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, Mortensen J, Möller-Nielsen C, Hanberg-Sörensen F, Hokland M. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513–516. doi:10.1002/bjs.1800790613.PubMedCrossRef

11.

Craig SR, Adam DJ, Yap PL, Leaver HA, Elton RA, Cameron EWJ, Snag CTM, Walker WS. Effect of blood transfusion on survival after esophagogastrectomy for carcinoma. Ann Thorac Surg. 1998;66:356–361. doi:10.1016/S0003-4975(98)00460-3.PubMedCrossRef

12.

Council of Europe. Guide to the preparation, use and quality assurance of blood components. 13th edn. Strassbourg, France: Council of Europe Publishing, 2007.

13.

Schneider PM, Baldus SE, Metzger R, Kocher M, Bongartz R, Bollschweiler E, Schaefer H, Thiele J, Dienes HP, Mueller RP, Hoelscher AH. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg. 2005;242:684–692. doi:10.1097/01.sla.0000186170.38348.7b.PubMedCrossRef

14.

LeBlanc M. Tree-based methods for prognostic stratification. In Crowley J, ed. Handbook of statistics in clinical oncology 2001. New York: Marcel Decker, 2001, pp 457–471.

15.

Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481. doi:10.2307/2281868.CrossRef

16.

Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: Good practice and pitfalls. Lancet 2002;359:1686–1689. doi:10.1016/S0140-6736(02)08594-X.PubMedCrossRef

17.

Motoyama S, Okuyama M, Kitamura M, Saito R, Kamata S, Murata K, Ogawa JI. Use of autologous instead of allogeneic blood transfusion during esophagectomy prolongs disease-free survival among patients with recurrent esophageal cancer. J Surg Oncol 2004;87:26–31. doi:10.1002/jso.20064.PubMedCrossRef

18.

Takemura M, Osugi H, Higashino M, Takada N, Lee S, Kinoshita H. Effects of substituting allogenic blood transfusion with autologous blood transfusion on outcomes after radical oesophagectomy for cancer. Ann Thorac Cardiovasc Surg 2005;11:293–300.PubMed

19.

Jensen LS, Hokland M, Nielsen HJ. A randomized controlled study of the effect of bedside leucocyte depletion on the imunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1996;83:973–977. doi:10.1002/bjs.1800830727.PubMedCrossRef

20.

Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996;348:841–845. doi:10.1016/S0140-6736(96)06168-5.PubMedCrossRef

21.

Jensen LS, Puho E, Pedersen L, Mortensen FV, Sorensen HT. Long-term survival after colorectal surgery associated with buffy-coat-poor and leucocyte-depleted blood transfusion: a follow-up study. Lancet 2005;365:681–682.PubMed

22.

Houbiers JGA, Brand A, van de Watering LMG, Hermans J, Verwey PJM, Bijnen AB, Pahlplatz P, Eeftinck Schattenkerk M, Wobbes T, de Vries JE, Klementschitsch P, van de Maas AHM, van de Velde CJH. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994;344:573–578. doi:10.1016/S0140-6736(94)91965-8.PubMedCrossRef

23.

Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg 1995;82:582–587. doi:10.1002/bjs.1800820505.PubMedCrossRef

Title: Leukocyte Depletion in Allogeneic Blood Transfusion Does Not Change the Negative Influence on Survival Following Transthoracic Resection for Esophageal Cancer
Authors: Frederike C. Ling
Arnulf H. Hoelscher
Daniel Vallböhmer
Daniel Schmidt
Susanne Picker
Birgit S. Gathof
Elfriede Bollschweiler
Paul M. Schneider
Publication date: 01-04-2009
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 4/2009
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-008-0787-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Leukocyte Depletion in Allogeneic Blood Transfusion Does Not Change the Negative Influence on Survival Following Transthoracic Resection for Esophageal Cancer

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2009

Hemorrhage-Induced Hepatic Injury and Hypoperfusion can be Prevented by Direct Peritoneal Resuscitation

Hepatic Metastasectomy for Testicular Germ Cell Tumors: Is it worth it?

Risk Prediction Scores for Postoperative Mortality After Esophagectomy: Validation of Different Models

Does Low Molecular Weight Heparin Impair Anastomotic Wound Healing?

Jejunal Gallstone Ileus: An Unusual Site of Gallstone Impaction

Colectomy in Patients with Acute Colitis: A Systematic Review